Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In early August, a court in the southern Indian city of Chennai dismissed a lawsuit filed by pharmaceutical giant Novartis. James Love, director of the nonprofit organization Knowledge Ecology International, explains the local lawsuit’s global impact.
The death of a participant in a gene therapy trial has thrown the entire field into question–as it did once before in 1999. Can the field survive this second setback? Virginia Hughes investigates.
Parents of autistic children are mounting a vicious campaign against scientists who refute the link between vaccines and autism. Virginia Hughes takes the temperature of the escalating debate.
India surprised the world when it announced in July that it is home to 2.5 million infected individuals—fewer than half of the previous estimate. Ashok Alexander, director of the Bill & Melinda Gates Foundation's Indian initiative on AIDS explains why the dramatically lower numbers are no reason to celebrate.
Good reviewers underpin the quality of a journal. At Nature Medicine, what do we seek in our reviewers? And how do we retain the best in the face of the plethora of requests from an increasing number of journals?